Instrucciones de búsqueda:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Navegar por los elementos (39 total)
-
Autor: McElroy, Anita K., Rama S. Akondy, David R. McLlwain, Han Chen, Zach Bjornson-Hooper, Nilanjan Mukherjee, Aneesh K. Mehta, Garry Nolan, Stuart T. Nichol, and Christina F. Spiropoulou.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-05-21
Descripción: A complete understanding of human immune responses to Ebola virus infection is limited by the availability of specimens and the requirement for biosafety level 4 (BSL-4) containment. -
Autor: National Institutes of Health (NIH)
Tema: Research
Tipo de elemento: Webinar
Fecha de actualización: 2018-11-02
Descripción: 13th annual Philip S. Chen, Jr., Ph.D. Distinguished Lecture on Innovation and Technology Transfer. Dr. Nancy Sullivan will present “Lightning Chess: How Host Immunity Gains a Winning Position Against Ebolavirus Infection.” Dr. Sullivan is Senior… -
Autor: Poland, Gregory A., Inna G. Ovsyannikova, and Richard B. Kennedy.
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-10-13
Descripción: Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such as hyperimmune globulin and convalescent human plasma, and to developing… -
Autor: Prendecki, Maria, Candice Clarke, Jonathan Brown, Alison Cox, Sarah Gleeson, Mary Guckian, Paul Randell, Alessia Dalla Pria, Liz Lightstone, Xiao-Ning Xu, Wendy Barclay, Stephen P. McAdoo, Peter Kelleher, and Michelle Willicombe.
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2021-02-25
Descripción: The rapid implementation of SARS-CoV-2 vaccination is now a global health-care priority. Successful phase 3 trial outcomes have been reported for numerous vaccines that induce robust humoral and cellular immune responses against the SARS-CoV-2 spike… -
Autor: Southern, T. R., L. D. Racsa, C. G. Albarino, P. D. Fey, S. H. Hinrichs, C. N. Murphy, V. L. Herrera, A. R. Sambol, C. E. Hill, E. L. Ryan, C. S. Kraft, S. Campbell, T. K. Sealy, A. Schuh, J. C. Ritchie, G. M. Lyon, 3rd, A. K. Mehta, J. B. Varkey, B.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2015-09-01
Descripción: Rapid, reliable, and easy-to-use diagnostic assays for detection of Zaire ebolavirus (ZEBOV) are urgently needed. -
Autor: Sridhar V Basavaraju, Monica E Patton, Kacie Grimm, Mohammed Ata Ur Rasheed, Sandra Lester, Lisa Mills, Megan Stumpf, Brandi Freeman, Azaibi Tamin, Jennifer Harcourt, Jarad Schiffer, Vera Semenova, Han Li, Bailey Alston, Muyiwa Ategbole, Shanna…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-11-30
Descripción: SARS-CoV-2, the virus that causes COVID-19 disease, was first identified in Wuhan, China in December 2019, with subsequent worldwide spread. The first U.S. cases were identified in January 2020. -
Autor: Suthar, M. S., M. G. Zimmerman, R. C. Kauffman, G. Mantus, S. L. Linderman, W. H. Hudson, A. Vanderheiden, L. Nyhoff, C. W. Davis, O. Adekunle, M. Affer, M. Sherman, S. Reynolds, H. P. Verkerke, D. N. Alter, J. Guarner, J. Bryksin, M. C. Horwath, C.…
Tema: Laboratory
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-23
Descripción: SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection. We… -
Autor: Suthar, Mehul S., Matthew G. Zimmerman, Robert C. Kauffman, Grace Mantus, Susanne L. Linderman, William H. Hudson, Abigail Vanderheiden, Lindsay Nyhoff, Carl W. Davis, Oluwaseyi Adekunle, Maurizio Affer, Melanie Sherman, Stacian Reynolds, Hans P.…
Tema: Research
Tipo de elemento: Publicación
Fecha de actualización: 2020-06-23
Descripción: SARS-CoV-2, the virus responsible for COVID-19, is causing a devastating worldwide pandemic, and there is a pressing need to understand the development, specificity, and neutralizing potency of humoral immune responses during acute infection.